BioSapien
BioSapien utilizes previously FDA-approved products to create a patented drug delivery platform for local slow-release.
Based based in United States, BioSapien works in health and life sciences, founded in 2018.
Within the health and life sciences space, the company focuses on its core offering rather than a broad product line.
The business is associated with United States.
The company is listed at the Seed stage of development.
The company reports a headcount in the 2-10 range.
Total disclosed funding stands at about $248K.
| Sector | Health and Life Sciences |
|---|---|
| Country | United States |
| Founded | 2018 |
| Employees | 2-10 |
| Stage | Seed |
| Total funding | $248,000 |
Website: biosapien.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account